What Researchers Did
Researchers treated 70 patients suffering from refractory osteomyelitis with hyperbaric oxygen therapy.
What They Found
All 70 patients showed improvement after receiving hyperbaric oxygen treatment. Furthermore, 63% of these patients remained free of disease following the intervention.
What This Means for Canadian Patients
This treatment could offer a potential option for Canadian patients with osteomyelitis that has not responded to standard therapies. Patients should discuss with their healthcare provider if hyperbaric oxygen therapy is suitable as a supplemental treatment.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants.
Study Limitations
A significant limitation of this study is the absence of a control group, making it difficult to definitively attribute the observed improvements solely to hyperbaric oxygen treatment.